Henry M Jackson Foundation For The Advancement Of Military Medicine
- Assets
- $242.5m
- Revenue
- $530.7m
- Investments
- $23.7m
- Employees
- 2,792
- Location
- Bethesda, MD
- Founding
- 12/1983
- Data as of
- 09/2022
- EIN
- 52-1317896
Organization Overview
Henry M Jackson Foundation For The Advancement Of Military Medicine is located in Bethesda, MD. The organization was established in 1983. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 09/2023, Henry M Jackson Foundation For The Advancement Of Military Medicine employed 2,792 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Henry M Jackson Foundation For The Advancement Of Military Medicine is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2022, Henry M Jackson Foundation For The Advancement Of Military Medicine generated $530.7m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 1.5% each year. All expenses for the organization totaled $542.5m during the year ending 09/2022. While expenses have increased by 2.1% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
WITH THE MISSION TO ADVANCE MILITARY MEDICINE, THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC (HJF) IS A GLOBAL NONPROFIT ORGANIZATION PROVIDING INVESTIGATORS AND CLINICIANS SCIENTIFIC, ADMINISTRATIVE AND PROGRAM MANAGEMENT SERVICES. HJF SERVES AS A TRUSTED AND RESPONSIVE LINK BETWEEN THE MILITARY MEDICAL COMMUNITY, FEDERAL AND PRIVATE PARTNERS, AND THE MILLIONS OF AMERICAN SERVICE FAMILIES , VETERANS AND CIVILIANS WHO BENEFIT FROM THE MEDICAL RESEARCH ADVANCES THAT RESULT FROM THIS WORK.
Describe the Organization's Program Activity:
Part 3 - Line 4a
AS TRUSTED PARTNERS WITH MILITARY MEDICAL RESEARCHERS, IMPORTANT HJF ACCOMPLISHMENTS INCLUDE ATTRACTING, MANAGING AND RETAINING HIGHLY QUALIFIED SCIENTIFIC STAFF TO SUPPORT THE PRIORITIES OF U.S. MILITARY MEDICINE. WHETHER IT IS THE SENIOR SCIENTIST TO LEAD MAJOR INITIATIVES AND WORK COLLABORATIVELY WITH U.S. GOVERNMENT SCIENTISTS, OR LAB TECHS TO PERFORM ONGOING RESEARCH FUNCTIONS, HJF HIRES THE BEST AND BRIGHTEST TALENT TO ACCELERATE INNOVATIONS NECESSARY TO ADVANCE MILITARY MEDICINE. IN FY2023, HJF CELEBRATED 40 YEARS OF MEETING ITS MISSION OF ADVANCING MILITARY MEDICINE. HJF UNDERTOOK SEVERAL RESEARCH INITIATIVES IN NEW GEOGRAPHIC REGIONS, ONE OF WHICH WAS TO EVALUATE WARTIME MEDICAL CARE DELIVERY PROVIDED BY THE UKRAINE MINISTRY OF HEALTH. WE LAUNCHED A NEW INNOVATION ECOSYSTEM INITIATIVE WITH MULTIPLE NEW PARTNERS, INCLUDING A HIGH-PROFILE EVENT WITH THE MARYLAND TECHNOLOGY DEVELOPMENT CORPORATION (TEDCO). WE ALSO STRENGTHENED OUR COLLABORATIONS ACROSS U.S. FEDERAL AGENCIES, UNIVERSITIES, NON-GOVERNMENTAL ORGANIZATIONS, AND PRIVATE INDUSTRY. SUPPORTED HJF PROGRAMS PEPFAR: SINCE 2005, HJF MEDICAL RESEARCH INTERNATIONAL HAS IMPLEMENTED THE U.S. PRESIDENT'S EMERGENCY PLAN FOR AIDS RELEASE (PEPFAR) HIV PREVENTION, CARE AND TREATMENT SERVICES ACROSS FOUR COUNTRIES IN AFRICA. THIS YEAR MARKED THE 20TH ANNIVERSARY OF THE PEPFAR PROGRAM, AND WITH IMPROVED TREATMENTS, HIV IS NO LONGER A DEATH SENTENCE, AND STIGMA AROUND THE DISEASE HAS DECREASED IN MANY AFRICAN COMMUNITIES. MHRP: THE U.S. MILITARY HIV RESEARCH PROGRAM (MHRP) IDENTIFIED TWO NOVEL BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES THAT SHOW PROMISE FOR THE PREVENTION AND TREATMENT OF HIV, AND THEY MAY BE PARTICULARLY USEFUL IN MILITARY SETTINGS. HJF'S GLOBAL INFECTIOUS DISEASES PORTFOLIO CONTINUES TO BROADEN ITS SERVICES TO HELP DEFEAT CURRENT AND FUTURE INFECTIOUS DISEASES THROUGH SUPPORT OF THE EMERGING INFECTIOUS DISEASE, DIAGNOSTIC AND COUNTERMEASURES, AND ONE HEALTH BRANCHES AT WALTER REED ARMY INSTITUTE OF RESEARCH. IDCRP: THE INFECTIOUS DISEASE CLINICAL RESEARCH PROGRAM (IDCRP) HAS MORE THAN 100 HJF EMPLOYEES ACROSS MORE THAN 35 PARTNER CLINICAL SITES, ALONG WITH MANY ONGOING COLLABORATIONS WITH ACADEMIA, INDUSTRY AND OTHER GOVERNMENT PARTNERS. FOR FY2023, ONE OF IDCRP'S EXAMPLE STUDIES IS A FOLLOW-ON TRIAL TO EVALUATE THE EFFICACY OF A LOWER DOSE OF RIFAXIMIN TO TREAT TRAVELERS' DIARRHEA. ACESO: THE AUSTERE ENVIRONMENTS CONSORTIUM FOR ENHANCED SEPSIS OUTCOMES (ACESO) CONTINUED ITS EFFORTS TO DISCOVER HOST-BIOMARKERS OF SEVERE INFECTIONS AND SEPSIS UTILIZING ADVANCED DATA ANALYTICS AND ARTIFICIAL INTELLIGENCE/MACHINE LEARNING, SET UP AN INTUITIVE CLINICAL DATA MANAGEMENT SYSTEM, TRANSITION HOST-BIOMARKERS TO POINT-OF-CARE DEVICES THAT ARE BEING VALIDATED AT HOST COUNTRY INSTITUTIONS, PUBLISH PEER-REVIEWED MANUSCRIPTS OF THE SCIENTIFIC COMMUNITY AND EXPAND ITS OBSERVATIONAL STUDIES IN SEVERE INFECTIONS AND SEPSIS TO MADAGASCAR AND PERU. IN FY2023, HJF RECEIVED MORE THAN 270 NEW AWARDS, GRANTS, AGREEMENTS, OR CONTRACTS. HJF HAD MORE THAN 1400 ACTIVE RESEARCH PROTOCOLS DURING FY2023 WITH A PRESENCE IN 17 COUNTRIES, AND APPROXIMATELY 2,800 TEAMMATES AT SITES ON FOUR CONTINENTS.
ENDOWMENTS DELIVERED SIGNIFICANT PROGRAM SERVICES AND SUPPORT TO THE UNIFORMED SERVICES UNIVERSITY FOR THE HEALTH SCIENCES (USU), PARTICULARLY FOR THE SCHOOL OF MEDICINE AND THE CLINICAL SCIENCES DEPARTMENT OF SURGERY AND DEPARTMENT OF DERMATOLOGY. PROGRAMS INCLUDE FELLOWSHIP GRANTS FOR GRADUATE STUDENTS STUDYING MILITARY MEDICINE AT USU. HJF FELLOWSHIP AWARDS PROVIDE TRAVEL, EDUCATION, AND TRAINING SUPPORT.
EDUCATION ACCOUNTS PROVIDED EDUCATIONAL, TRAINING, AND OTHER APPROVED INITIATIVES RELATED TO ADVANCING MILITARY MEDICINE. SAMPLES OF PROJECTS FUNDED THROUGH EDUCATIONAL INITIATIVES INCLUDE THE PROVISIONING OF TEXTBOOKS, TRAVEL TO MEDICAL CONFERENCES OR COURSES, SUPPORT FOR EXAMS, AND MANUSCRIPT PUBLICATION EXPENSES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Name Not Listed Director | Trustee | 1 | $0 |
Name Not Listed Director-Chairman | Trustee | 1 | $0 |
Name Not Listed Director | Trustee | 1 | $0 |
Name Not Listed Director | Trustee | 1 | $0 |
Name Not Listed Director | Trustee | 1 | $0 |
Name Not Listed Ex Officio Director | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
The Regents Of The University Of Michigan Research Services | 9/29/23 | $4,202,547 |
University Of California At San Francisco Research Services | 9/29/23 | $33,920,450 |
Indiana University Research Services | 9/29/23 | $3,530,411 |
Makerere Universitywalter Reed Project Research Services | 9/29/23 | $3,307,213 |
Windber Research Institute Research Services | 9/29/23 | $7,918,090 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $608,150 |
| Related organizations | $0 |
| Government grants | $444,762,423 |
| All other contributions, gifts, grants, and similar amounts not included above | $398,274 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $445,768,847 |
| Total Program Service Revenue | $89,746,267 |
| Investment income | $146,350 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $2,598,209 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$7,545,884 |
| Net Income from Fundraising Events | -$61,203 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $530,652,586 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $4,051,845 |
| Compensation of current officers, directors, key employees. | $4,051,845 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $187,054,969 |
| Pension plan accruals and contributions | $11,452,259 |
| Other employee benefits | $28,641,490 |
| Payroll taxes | $14,047,735 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $1,434,000 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $214,652,914 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $11,447,246 |
| Travel | $3,934,326 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $499,688 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $2,551,475 |
| Insurance | $722,372 |
| All other expenses | $4,362,724 |
| Total functional expenses | $542,512,800 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $2,646,422 |
| Savings and temporary cash investments | $24,153,220 |
| Pledges and grants receivable | $123,342,989 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $7,969,113 |
| Net Land, buildings, and equipment | $9,199,162 |
| Investments—publicly traded securities | $46,813,136 |
| Investments—other securities | $23,721,508 |
| Investments—program-related | $0 |
| Intangible assets | $4,693,933 |
| Other assets | $0 |
| Total assets | $242,539,483 |
| Accounts payable and accrued expenses | $70,559,152 |
| Grants payable | $0 |
| Deferred revenue | $9,453,417 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $18,305,024 |
| Total liabilities | $98,317,593 |
| Net assets without donor restrictions | $93,492,529 |
| Net assets with donor restrictions | $50,729,361 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $242,539,483 |